Heartland Group Holdings Limited logo

Ongoing Disclosure Notice – Various

Insider Disclosure26 September 2023HGHFinancials

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Sep-23

Date of last disclosure:

18-Apr-23

Director or senior manager giving disclosure

Full name(s):

Michael Jonathan Drumm

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Not Applicable

Position held in listed issuer:

Group Chief Operating Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heart land Group

Holdings Limit ed (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Regist ered Holder and Benef icial Ow ner

For that relevant interest-

Number held in class before acquisition or disposal:

115,251

Number held in class after acquisition or disposal:

260,496

Current registered holder(s):

Michael Jonat han Drumm

Registered holder(s) once transfers are registered:

Not Applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 3

Details of transactions requiring disclosure-
Date of transaction:19 September 202319 September 2023

Nature of transaction:

Issue of shares and transfer of treasury

stock pursuant to the vesting of

performance rights under the Heartland

Performance Rights Plan 2021 tranche

(PR Tranche) for no cash consideration.

Further details of the PR Tranche is

included within Heartland’s financial

statements.

A proportion of the shares issued to

Michael Drumm pursuant to vesting of the

performance rights were immediately

acquired by Heartland for cash

consideration in order to fund the tax

liability arising for the recipients upon the

issue of shares and transfer of treasury

stock under the PR Tranche. More

information about this can be found in the

‘LTI Buyback Disclosure Document’

released on 29 August 2023 and the

Capital Change Noticed released on 20

September 2023 by Heartland.

Name of any other party or parties to the transaction (if known):

Heartland Group Holdings LimitedHeartland Group Holdings Limited

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil$1.76281105 per share

Number of financial products to which the transaction related:

231,85390,423

Date of transaction:20 September 2023

Nature of transaction:

Dividend Reinvestment Plan

Name of any other party or parties to the transaction (if known):

Not applicable

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by $6,434.11

Number of financial products to which the transaction related:

3,815

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:Not applicable

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Not applicable

Date of the prior written clearance (if any):

Not applicable

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:26 September 2023

Name and title of authorised person:Phoebe Gibbons, General Counsel


Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Sep-23

Date of last disclosure:

23-Sep-22

Director or senior manager giving disclosure

Full name(s):

Andrew Peter Dixson

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Not Applicable

Position held in listed issuer:

Chief Financial Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heart land Group

Holdings Limit ed (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Regist ered Holder and Benef icial Ow ner

For that relevant interest-

Number held in class before acquisition or disposal:

338,796

Number held in class after acquisition or disposal:

515,584

Current registered holder(s):

Andrew Pet er Dixson

Registered holder(s) once transfers are registered:

Not Applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:19 September 202319 September 2023

Nature of transaction:

Issue of shares and transfer of treasury

stock pursuant to the vesting of

performance rights under the Heartland

Performance Rights Plan 2021 tranche

(PR Tranche) for no cash consideration.

Further details of the PR Tranche is

included within Heartland’s financial

statements.

A proportion of the shares issued to

Andrew Dixson pursuant to vesting of the

performance rights were immediately

acquired by Heartland for cash

consideration in order to fund the tax

liability arising for the recipients upon the

issue of shares and transfer of treasury

stock under the PR Tranche. More

information about this can be found in the

‘LTI Buyback Disclosure Document’

released on 29 August 2023 and the

Capital Change Noticed released on 20

September 2023 by Heartland.

Name of any other party or parties to the transaction (if known):

Heartland Group Holdings LimitedHeartland Group Holdings Limited

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil$1.76281105 per share

Number of financial products to which the transaction related:

289,817113,029

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:Not applicable

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Not applicable

Date of the prior written clearance (if any):

Not applicable

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:26 September 2023

Name and title of authorised person:Phoebe Gibbons, General Counsel

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • AGL — Accordant Group Limited: Ongoing disclosure Notice
    2023-09-14

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Accordant Group Limited Date this disclosure made: 15-Sep-23 Date of last disclosu…”

  • TAH — Third Age Health Services Limited: D&O Ongoing Disclosure Notice
    2023-07-07

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 7 July 2023 Date of l…”

  • VHP — Vital Healthcare Property Trust: D&O ongoing disclosure – Aaron Hockly DRP
    2023-09-25

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Vital Healthcare Property Trust Date this disclosure made: 26 September 2023 Date…”